WHO SARS collaborative research project

The WHO SARS collaborative research project was an international network of eleven laboratories that identified the coronavirus as the cause of SARS in approximately a month. Rather than assigning discovery to a lone scientist or a commanding institution, the episode shows how laboratories could pursue different lines of inquiry independently while exchanging evidence quickly enough to build a collective conclusion. Its achievement became an example of science as coordinated, open-ended work: a natural cause was established through distributed investigation, and its standing as scientific knowledge depended on the wider community’s scrutiny and acceptance.

Origins and Organization

In early February 2003, China’s Ministry of Health informed the World Health Organization that 305 people in Guangdong Province had been stricken by a severe respiratory disease since November 2002; five had died. Tests for influenza viruses were negative. Within weeks, a man returning from China and Hong Kong became seriously ill in Hanoi, while workers at a Hong Kong hospital developed similar symptoms. By early March it was evident that SARS was not a new kind of flu but a new disease. The WHO issued a global warning, activated a surveillance system to track outbreaks, and sought to identify the disease’s cause—knowledge that could support testing and, eventually, a vaccine.

On March 15 and 16, the WHO contacted eleven laboratories in France, Germany, the Netherlands, Japan, the United States, Hong Kong, Singapore, Canada, the United Kingdom, and China. They all agreed to cooperate, and on March 17 began what the WHO called a “collaborative multicenter research project.” The organization brought the network into being, but it did not command the participating laboratories as a central research directorate. The WHO had no real authority to compel academic or government laboratories to carry out particular investigations; the collaboration therefore depended on the laboratories’ agreement to share relevant data and speak every morning, and on their own decisions about how to divide the work.

Evidence in Circulation

The network gave collaboration a practical daily rhythm. Researchers held teleconferences to discuss results and possible next steps, while a WHO website carried electron-microscope photographs of viruses isolated from SARS patients, analyses, and test results. Laboratories also exchanged virus samples, so they could check one another’s work and learn from it. Sharing was not an afterthought to the investigation: it let different teams examine the same material in parallel, increasing the speed and effectiveness of the search.

In the first days, the researchers considered and ruled out possible causes, including viruses present in some patients’ samples but absent from others. By March 21, scientists at Hong Kong University had isolated a promising candidate. That same day, researchers at the United States Centers for Disease Control independently isolated a virus that looked under the electron microscope like a coronavirus. The identification was surprising because coronaviruses can cause serious illness in animals, whereas their effects in humans were generally mild. Over the following week, laboratories found the coronavirus in a wide range of samples from people diagnosed with SARS, and teams in Germany, the Netherlands, and Hong Kong began sequencing it. In early April, monkeys infected with the virus in a Netherlands laboratory developed full-blown SARS. On April 16, only a month after the collaboration began, the laboratories announced that the coronavirus caused the disease.

A Collective Discovery

The account distinguishes an important initial observation from the proof that made the observation consequential. Electron microscopist Cynthia Goldsmith, working at the Centers for Disease Control and Prevention laboratory in Atlanta, was the person known to have first spotted the coronavirus. But that recognition alone did not establish that the virus caused SARS. It took weeks of testing by laboratories around the world to connect the virus to the disease; the investigations that eliminated other candidates also narrowed the field and contributed to the result. The discovery cannot therefore be credited to Goldsmith alone, to the Hong Kong team, or to any single institution. The WHO’s account described the laboratories as having “collectively . . . discovered” the coronavirus. Work that any one laboratory might have pursued for months or years took the network weeks.

The achievement depended on more than parallel effort. Each laboratory could follow the lines of investigation it considered most promising and use its particular analytical strengths, while the shared samples, discussions, and results made discoveries and corrections available to the others in real time. No leader prescribed which viruses or samples each lab had to study or dictated the exchange of information. Instead, the laboratories organized the division of work themselves. The absence of top-down direction was partly a consequence of the WHO’s limited authority, but in this case that constraint became an advantage: autonomy and coordination operated together rather than as competing principles.

Scientific Knowledge and Significance

The project was unusually broad and fast, yet its basic practice reflected a wider feature of modern science. Research is collective not only when many people co-author a paper or work on the same project, but also because scientific results and data are made available for others to inspect, challenge, and use in new work. Findings circulate rather than remaining the private property of their first investigators. Even studies that fail to confirm a hypothesis can help other researchers by showing which paths need not be pursued. The SARS search made this interdependence visible: the network’s answer emerged from evidence distributed among laboratories and from the work that ruled out alternatives, not from an isolated flash of insight.

The project also clarifies the difference between a disease’s physical cause and the scientific establishment of that cause. The coronavirus caused SARS before the WHO announced the finding. But it became an accepted scientific explanation only after other researchers could examine the evidence and accept that it supported the conclusion. Laboratories around the world could then work on potential tests and vaccines on the basis of a consensus reached through scrutiny and shared results. Most scientists do not personally repeat every experiment on which their work relies; they depend on other researchers’ data and on the community’s judgment about whether those results are credible. This reliance is not a claim that truth is merely a matter of opinion: the virus’s causal role does not depend on a vote. Rather, the project shows how collective investigation and informed trust allow an individual result to become usable common knowledge.